polypharmacy

Joseph, R. M., Knaggs, R. D., Coupland, C. A. C., Taylor, A., Vinogradova, Y., Butler, D., et al. (2023). Frequency and impact of medication reviews for people aged 65 years or above in UK primary care: an observational study using electronic health records. Bmc Geriatr, 23, 435. http://doi.org/10.1186/s12877-023-04143-2

View

Jeffery, A., Bhanu, C., Walters, K., Wong, I. C., Osborn, D., & Hayes, J. F. (2023). Polypharmacy and antidepressant acceptability in comorbid depression and type 2 diabetes: a cohort study using UK primary care data. Br J Gen Pract, 73, e392-e398. http://doi.org/10.3399/bjgp.2022.0295

View

Subramanian, A., Azcoaga-Lorenzo, A., Anand, A., Phillips, K., Lee, S. I., Cockburn, N., et al. (2023). Polypharmacy during pregnancy and associated risk factors: a retrospective analysis of 577 medication exposures among 1.5 million pregnancies in the UK, 2000-2019. Bmc Med, 21, 21. http://doi.org/10.1186/s12916-022-02722-5

View

Elhussein, L., Jödicke, A. M., He, Y., Delmestri, A., Robinson, D. E., . Y. Strauss, V., & Prieto-Alhambra, D. (2023). Characterising complex health needs and the use of preventive therapies in the older population: a population-based cohort analysis of UK primary care and hospital linked data. Bmc Geriatr, 23, 58. http://doi.org/10.1186/s12877-023-03770-z

View

Jeffery, A., Bhanu, C., Walters, K., Wong, I. C. K., Osborn, D., & Hayes, J. F. (2022). Association between polypharmacy and depression relapse in individuals with comorbid depression and type 2 diabetes: a UK electronic health record study. Br J Psychiatry, 1-7. http://doi.org/10.1192/bjp.2022.160

View